-
Australia's Head backs struggling opening partner Weatherald
-
'Make emitters responsible': Thailand's clean air activists
-
Zelensky looks to close out Ukraine peace deal at Trump meet
-
MCG curator in 'state of shock' after Ashes Test carnage
-
Texans edge Chargers to reach NFL playoffs
-
Osimhen and Mane score as Nigeria win to qualify, Senegal draw
-
Osimhen stars as Nigeria survive Tunisia rally to reach second round
-
How Myanmar's junta-run vote works, and why it might not
-
Watkins wants to sicken Arsenal-supporting family
-
Arsenal hold off surging Man City, Villa as Wirtz ends drought
-
Late penalty miss denies Uganda AFCON win against Tanzania
-
Watkins stretches Villa's winning streak at Chelsea
-
Zelensky stops in Canada en route to US as Russia pummels Ukraine
-
Arteta salutes injury-hit Arsenal's survival spirit
-
Wirtz scores first Liverpool goal as Anfield remembers Jota
-
Mane rescues AFCON draw for Senegal against DR Congo
-
Arsenal hold off surging Man City, Wirtz breaks Liverpool duck
-
Arsenal ignore injury woes to retain top spot with win over Brighton
-
Sealed with a kiss: Guardiola revels in Cherki starring role
-
UK launches paid military gap-year scheme amid recruitment struggles
-
Jota's children join tributes as Liverpool, Wolves pay respects
-
'Tired' Inoue beats Picasso by unanimous decision to end gruelling year
-
Thailand and Cambodia declare truce after weeks of clashes
-
Netanyahu to meet Trump in US on Monday
-
US strikes targeted IS militants, Lakurawa jihadists, Nigeria says
-
Cherki stars in Man City win at Forest
-
Schwarz records maiden super-G success, Odermatt fourth
-
Russia pummels Kyiv ahead of Zelensky's US visit
-
Smith laments lack of runs after first Ashes home Test loss for 15 years
-
Russian barrage on Kyiv kills one, leaves hundreds of thousands without power
-
Stokes, Smith agree two-day Tests not a good look after MCG carnage
-
Stokes hails under-fire England's courage in 'really special' Test win
-
What they said as England win 4th Ashes Test - reaction
-
Hong Kongers bid farewell to 'king of umbrellas'
-
England snap 15-year losing streak to win chaotic 4th Ashes Test
-
Thailand and Cambodia agree to 'immediate' ceasefire
-
Closing 10-0 run lifts Bulls over 76ers while Pistons fall
-
England 77-2 at tea, need 98 more to win chaotic 4th Ashes Test
-
Somalia, African nations denounce Israeli recognition of Somaliland
-
England need 175 to win chaotic 4th Ashes Test
-
Cricket Australia boss says short Tests 'bad for business' after MCG carnage
-
Russia lashes out at Zelensky ahead of new Trump talks on Ukraine plan
-
Six Australia wickets fall as England fight back in 4th Ashes Test
-
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
-
Dental Implant Financing and Insurance Options in Georgetown, TX
-
Man Utd made to 'suffer' for Newcastle win, says Amorim
-
Morocco made to wait for Cup of Nations knockout place after Egypt advance
-
Key NFL week has playoff spots, byes and seeds at stake
-
Morocco forced to wait for AFCON knockout place after Mali draw
-
Dorgu delivers winner for depleted Man Utd against Newcastle
US cracks down on 'tranq' drug linked to fatal overdoses
The United States announced Tuesday a crackdown on unlawful imports of xylazine, an animal tranquilizer known as the "zombie drug" and which is increasingly linked to overdose deaths.
Xylazine, which also goes by the street name "tranq," has recently been found in illicitly manufactured fentanyl, heroin, cocaine and other drugs, presenting a "growing public health concern," the Food and Drug Administration (FDA) said.
"This action aims to prevent the drug from entering the US market for illicit purposes, while maintaining availability for its legitimate uses in animals," it said in a statement.
According to the National Institute on Drug Abuse, the percentage of all drug overdose deaths involving xylazine increased from two percent to 26 percent in the northeast state of Pennsylvania from 2015 to 2020.
Xylazine is typically used by veterinarians to sedate large animals such as horses and deer but the drug is not approved for use in humans.
It can slow breathing, blood pressure and heart rate to critically low levels and cause skin ulcers and abscesses that can lead to amputation.
The FDA said imports of xylazine would be subject to heightened scrutiny and seized if they appear to be unlawful.
"The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part of broader efforts the agency is undertaking to address this issue," FDA commissioner Robert Califf said.
Y.Nakamura--AMWN